Share price & Turnover
Calendar
2025-10-28 | Quarterly Report 2025-Q3 |
2025-07-18 | Quarterly Report 2025-Q2 |
2025-04-23 | Quarterly Report 2025-Q1 |
2025-04-03 | Annual General meeting |
2025-02-25 | Year-end Report 2024 |
2024-10-29 | Quarterly Report 2024-Q3 |
2024-10-15 | Ex-date Semi-Annual Dividend ORNAV 0.81 |
2024-10-15 | Ex-date Semi-Annual Dividend ORNBV 0.81 |
2024-08-08 | Quarterly Report 2024-Q2 |
2024-04-25 | Quarterly Report 2024-Q1 |
2024-03-21 | Ex-date Semi-Annual Dividend ORNBV 0.81 |
2024-03-21 | Ex-date Semi-Annual Dividend ORNAV 0.81 |
2024-03-20 | Annual General meeting |
2024-02-13 | Year-end Report 2023 |
2023-10-26 | Quarterly Report 2023-Q3 |
2023-07-17 | Quarterly Report 2023-Q2 |
2023-04-27 | Quarterly Report 2023-Q1 |
2023-03-23 | Ex-date Ordinary Dividend ORNBV 1.60 EUR |
2023-03-23 | Ex-date Ordinary Dividend ORNAV 1.60 EUR |
2023-03-22 | Annual General meeting |
2023-02-09 | Year-end Report 2022 |
2022-10-20 | Quarterly Report 2022-Q3 |
2022-07-15 | Quarterly Report 2022-Q2 |
2022-04-28 | Quarterly Report 2022-Q1 |
2022-03-24 | Ex-date Ordinary Dividend ORNBV 1.50 EUR |
2022-03-24 | Ex-date Ordinary Dividend ORNAV 1.50 EUR |
2022-03-23 | Annual General meeting |
2022-02-10 | Year-end Report 2021 |
2021-10-20 | Quarterly Report 2021-Q3 |
2021-07-19 | Quarterly Report 2021-Q2 |
2021-04-27 | Quarterly Report 2021-Q1 |
2021-03-26 | Ex-date Ordinary Dividend ORNAV 1.50 EUR |
2021-03-26 | Ex-date Ordinary Dividend ORNBV 1.50 EUR |
2021-03-25 | Annual General meeting |
2021-02-09 | Year-end Report 2020 |
2020-10-21 | Quarterly Report 2020-Q3 |
2020-07-17 | Quarterly Report 2020-Q2 |
2020-05-07 | Ex-date Ordinary Dividend ORNAV 1.50 EUR |
2020-05-07 | Ex-date Ordinary Dividend ORNBV 1.50 EUR |
2020-05-06 | Annual General meeting |
2020-04-28 | Quarterly Report 2020-Q1 |
2020-03-26 | Ex-date Ordinary Dividend ORNBV 1.50 EUR |
2020-02-05 | Year-end Report 2019 |
2019-10-23 | Quarterly Report 2019-Q3 |
2019-07-17 | Quarterly Report 2019-Q2 |
2019-04-25 | Quarterly Report 2019-Q1 |
2019-03-27 | Ex-date Ordinary Dividend ORNAV 1.50 EUR |
2019-03-27 | Ex-date Ordinary Dividend ORNBV 1.50 EUR |
2019-03-26 | Annual General meeting |
2019-02-06 | Year-end Report 2018 |
2018-10-24 | Quarterly Report 2018-Q3 |
2018-07-18 | Quarterly Report 2018-Q2 |
2018-04-24 | Quarterly Report 2018-Q1 |
2018-03-21 | Ex-date Ordinary Dividend ORNAV 1.45 EUR |
2018-03-21 | Ex-date Ordinary Dividend ORNBV 1.45 EUR |
2018-03-20 | Annual General meeting |
2018-02-07 | Year-end Report 2017 |
2017-10-26 | Quarterly Report 2017-Q3 |
2017-07-19 | Quarterly Report 2017-Q2 |
2017-05-18 | Capital Market Day 2017 |
2017-04-26 | Quarterly Report 2017-Q1 |
2017-03-23 | Ex-date Bonus Dividend ORNAV 0.2 |
2017-03-23 | Ex-date Ordinary Dividend ORNBV 1.35 EUR |
2017-03-23 | Ex-date Ordinary Dividend ORNAV 1.35 EUR |
2017-03-23 | Ex-date Bonus Dividend ORNBV 0.2 |
2017-03-22 | Annual General meeting |
2017-02-08 | Year-end Report 2016 |
2016-10-25 | Quarterly Report 2016-Q3 |
2016-07-19 | Quarterly Report 2016-Q2 |
2016-04-27 | Quarterly Report 2016-Q1 |
2016-03-23 | Ex-date Ordinary Dividend ORNBV 1.30 EUR |
2016-03-23 | Ex-date Ordinary Dividend ORNAV 1.30 EUR |
2016-03-22 | Annual General meeting |
2016-02-02 | Year-end Report 2015 |
2015-10-27 | Quarterly Report 2015-Q3 |
2015-07-28 | Quarterly Report 2015-Q2 |
2015-05-26 | Capital Market Day 2015 |
2015-04-29 | Quarterly Report 2015-Q1 |
2015-03-25 | Ex-date Ordinary Dividend ORNAV 1.30 EUR |
2015-03-25 | Ex-date Ordinary Dividend ORNBV 1.30 EUR |
2015-03-24 | Annual General meeting |
2015-02-04 | Year-end Report 2014 |
2014-10-21 | Quarterly Report 2014-Q3 |
2014-07-29 | Quarterly Report 2014-Q2 |
2014-04-29 | Quarterly Report 2014-Q1 |
2014-03-26 | Ex-date Ordinary Dividend ORNBV 1.25 EUR |
2014-03-26 | Ex-date Ordinary Dividend ORNAV 1.25 EUR |
2014-03-25 | Annual General meeting |
2014-02-04 | Year-end Report 2013 |
2013-10-22 | Quarterly Report 2013-Q3 |
2013-07-30 | Quarterly Report 2013-Q2 |
2013-04-23 | Quarterly Report 2013-Q1 |
2013-03-20 | Ex-date Ordinary Dividend ORNBV 1.30 EUR |
2013-03-20 | Ex-date Ordinary Dividend ORNAV 1.30 EUR |
2013-03-19 | Annual General meeting |
2013-02-05 | Year-end Report 2012 |
2012-10-23 | Quarterly Report 2012-Q3 |
2012-07-31 | Quarterly Report 2012-Q2 |
2012-05-24 | Capital Market Day 2012 |
2012-04-24 | Quarterly Report 2012-Q1 |
2012-03-21 | Ex-date Ordinary Dividend ORNBV 1.30 EUR |
2012-03-21 | Ex-date Bonus Dividend ORNBV 0.12 |
2012-03-21 | Ex-date Bonus Dividend ORNAV 0.12 |
2012-03-21 | Ex-date Ordinary Dividend ORNAV 1.30 EUR |
2012-03-20 | Annual General meeting |
2012-02-07 | Year-end Report 2011 |
2011-10-25 | Quarterly Report 2011-Q3 |
2011-08-02 | Quarterly Report 2011-Q2 |
2011-04-27 | Quarterly Report 2011-Q1 |
2011-04-01 | Ex-date Ordinary Dividend ORNAV 1.20 EUR |
2011-04-01 | Ex-date Bonus Dividend ORNBV 0.06 |
2011-04-01 | Ex-date Ordinary Dividend ORNBV 1.20 EUR |
2011-04-01 | Ex-date Bonus Dividend ORNAV 0.06 |
2011-03-31 | Annual General meeting |
2011-02-09 | Year-end Report 2010 |
2010-10-26 | Quarterly Report 2010-Q3 |
2010-08-10 | Quarterly Report 2010-Q2 |
2010-04-27 | Quarterly Report 2010-Q1 |
2010-03-25 | Ex-date Bonus Dividend ORNAV 0.1 |
2010-03-25 | Ex-date Bonus Dividend ORNBV 0.1 |
2010-03-25 | Ex-date Ordinary Dividend ORNBV 1.00 EUR |
2010-03-25 | Ex-date Ordinary Dividend ORNAV 1.00 EUR |
2009-03-24 | Ex-date Ordinary Dividend ORNBV 0.95 EUR |
2009-03-24 | Ex-date Ordinary Dividend ORNAV 0.95 EUR |
2008-03-26 | Ex-date Ordinary Dividend ORNBV 1.00 EUR |
2007-04-03 | Ex-date Ordinary Dividend ORNAV 1.00 EUR |
2007-04-03 | Ex-date Ordinary Dividend ORNBV 1.00 EUR |
2006-03-22 | Ex-date Ordinary Dividend ORNBV 0.85 EUR |
2005-03-22 | Ex-date Ordinary Dividend ORNBV 0.55 EUR |
2005-03-22 | Ex-date Ordinary Dividend ORNAV 0.55 EUR |
2004-09-15 | Ex-date Bonus Dividend ORNAV 2.14 |
2004-09-15 | Ex-date Bonus Dividend ORNBV 2.14 |
2004-03-23 | Ex-date Ordinary Dividend ORNAV 1.60 EUR |
2004-03-23 | Ex-date Ordinary Dividend ORNBV 1.60 EUR |
2003-12-12 | Ex-date Bonus Dividend ORNBV 1.5 |
2003-12-12 | Ex-date Bonus Dividend ORNAV 1.5 |
2003-03-23 | Ex-date Ordinary Dividend ORNBV 0.93 EUR |
2003-03-23 | Ex-date Ordinary Dividend ORNAV 0.93 EUR |
2002-04-16 | Ex-date Ordinary Dividend ORNAV 1.10 EUR |
2002-04-16 | Ex-date Ordinary Dividend ORNBV 1.10 EUR |
2001-03-30 | Ex-date Ordinary Dividend ORNBV 1.20 EUR |
2001-03-30 | Ex-date Ordinary Dividend ORNAV 1.20 EUR |
2000-03-31 | Ex-date Ordinary Dividend ORNBV 1.18 EUR |
2000-03-31 | Ex-date Ordinary Dividend ORNAV 1.18 EUR |
1999-07-28 | Ex-date Bonus Dividend ORNAV 13.46 |
1999-07-28 | Ex-date Bonus Dividend ORNBV 13.46 |
1999-04-09 | Ex-date Ordinary Dividend ORNAV 6.50 EUR |
1999-04-09 | Ex-date Ordinary Dividend ORNBV 6.50 EUR |
1998-04-21 | Ex-date Ordinary Dividend ORNBV 7.50 EUR |
1998-04-21 | Ex-date Ordinary Dividend ORNAV 7.50 EUR |
1997-04-22 | Ex-date Ordinary Dividend ORNBV 5.00 EUR |
1997-04-22 | Ex-date Ordinary Dividend ORNAV 5.00 EUR |
1996-04-23 | Ex-date Ordinary Dividend ORNAV 4.00 EUR |
1996-04-23 | Ex-date Ordinary Dividend ORNBV 4.00 EUR |
Description
Country | Finland |
---|---|
List | Large Cap Helsinki |
Sector | Health care |
Industry | Drugs & Trade |
ORION CORPORATION
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS
17 FEBRUARY 2022 at 17.15 EET
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly or indirectly by BlackRock, Inc. and its funds increased on 16 February 2022 above five (5) per cent of Orion Corporation’s total shares.
Total positions of BlackRock, Inc. and its funds subject to notification:
% of shares and voting rights (total of point A) | % of shares and voting rights through financial instruments (total of point B) | Total of both in % (points A + B) | Total number of shares and voting rights of issuer | |
Resulting situation on the date on which threshold was crossed or reached | 5.07% shares Below 5% voting rights | 0.11% shares Below 5% voting rights | 5.18% shares Below 5% voting rights | 141,134,278 shares 801,859,012 voting rights |
Position of previous notification (if applicable) | 4.89% shares Below 5% voting rights | 0.15% shares Below 5% voting rights | 5.05% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed:
Point A: Shares and voting rights:
Class/type of shares ISIN code | Number of shares and voting rights | % of shares and voting rights | ||
Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |
FI0009014377 | 7,159,012 shares Below 5% voting rights | 5.07% shares Below 5% voting rights | ||
POINT A SUBTOTAL |
Point B: Financial instruments according to SMA 9:6a:
Type of financial instrument | Expiration date | Exercise / Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
Securities Lent | N/A | N/A | Physical | 161,148 shares Below 5% voting rights | 0.11% shares Below 5% voting rights |
CFD | N/A | N/A | Cash | 3,333 shares Below 5% voting rights | 0.00% shares Below 5% voting rights |
POINT B SUBTOTAL | 164,481 shares Below 5% voting rights | 0.11% shares Below 5% voting rights |
Orion Corporation
Timo Lappalainen President and CEO | Olli Huotari SVP, Corporate Functions |
Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.